MGX
CO:METAGENOMI
Metagenomi
- Stock
Last Close
1.65
21/11 21:00
Market Cap
162.97M
Beta: -
Volume Today
666.32K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -10.38M - | -14.63M 40.90% | -16.13M 10.30% | -13.01M 19.37% | -19.82M 52.37% | -19.29M 2.65% | -25.15M 30.34% | -10.74M 57.30% | |
depreciation and amortization | 492K - | 719K 46.14% | 841K 16.97% | 1.01M 20.21% | 1.15M 14.14% | 1.20M 4.07% | 1.27M 6.00% | 1.31M 2.83% | |
deferred income tax | |||||||||
stock based compensation | 495K - | 529K - | 656K 24.01% | 3.27M 398.17% | 2.47M 24.45% | 5.06M 104.82% | |||
change in working capital | 1.28M - | 81.69M 6,302.35% | -4.98M 106.10% | -10.13M 103.33% | -6.94M 31.46% | -4.37M 37.00% | -10.91M 149.45% | -20.75M 90.15% | |
accounts receivables | -1.27M - | -2.33M - | -1.60M 31.44% | 1.47M 192.29% | 369K 74.95% | 434K 17.62% | |||
inventory | |||||||||
accounts payables | 913K - | 1.21M 31.98% | -323K 126.80% | 1.56M 582.04% | -2.52M 262.04% | 3.16M 225.21% | -1.43M 145.11% | ||
other working capital | 1.28M - | 82.06M 6,330.64% | -7.79M 109.49% | -8.37M 7.46% | -8.88M 6.06% | -5.26M 40.77% | -10.36M 97.03% | -19.76M 90.69% | |
other non cash items | -6.82M - | 1.75M 125.59% | 905K 48.17% | 630K 30.39% | 918K 45.71% | 1.01M 10.24% | 1.10M 8.30% | 7.48M 582.21% | |
net cash provided by operating activities | -14.94M - | 67.73M 553.31% | -21.00M 131.00% | -26.09M 24.28% | -23.73M 9.05% | -20.59M 13.22% | -29.85M 44.96% | -26.31M 11.86% | |
investments in property plant and equipment | -3.28M - | -3.51M 6.95% | -2.67M 23.95% | -3.15M 18.07% | -2.26M 28.29% | -1.74M 23.11% | -915K 47.32% | -665K 27.32% | |
acquisitions net | |||||||||
purchases of investments | -78.22M - | -119.20M 52.40% | -49.78M 58.24% | -39.12M - | -174.66M 346.49% | -74.50M 57.34% | |||
sales maturities of investments | 42.85M - | 49.80M 16.21% | 34.21M 31.30% | 78.15M 128.44% | 101.49M 29.87% | 80.85M 20.34% | 62.13M 23.15% | ||
other investing activites | -12.92M - | ||||||||
net cash used for investing activites | -16.20M - | -38.87M 139.99% | -72.07M 85.39% | -18.72M 74.03% | 75.89M 505.41% | 60.63M 20.10% | -94.73M 256.24% | -13.04M 86.24% | |
debt repayment | |||||||||
common stock issued | 95.29M - | -1.33M - | 86.54M 6,587.03% | -2.03M 102.35% | |||||
common stock repurchased | |||||||||
dividends paid | |||||||||
other financing activites | -1.91M - | -1.33M 30.16% | |||||||
net cash used provided by financing activities | 95.29M - | 4.29M 95.49% | -39K 100.91% | -1.91M 4,797.44% | -1.33M 30.16% | 86.54M 6,587.03% | -2.03M 102.35% | ||
effect of forex changes on cash | |||||||||
net change in cash | -31.14M - | 124.15M 498.68% | -88.77M 171.50% | -44.85M 49.48% | 50.25M 212.04% | 38.71M 22.97% | -38.05M 198.29% | -41.38M 8.76% | |
cash at beginning of period | 97.50M - | 60.29M 38.17% | 190.51M 215.99% | 101.75M 46.59% | 56.90M 44.08% | 107.14M 88.32% | 145.85M 36.12% | 102.56M 29.68% | |
cash at end of period | 66.36M - | 184.44M 177.92% | 101.75M 44.84% | 56.90M 44.08% | 107.14M 88.32% | 145.85M 36.12% | 107.81M 26.08% | 61.18M 43.25% | |
operating cash flow | -14.94M - | 67.73M 553.31% | -21.00M 131.00% | -26.09M 24.28% | -23.73M 9.05% | -20.59M 13.22% | -29.85M 44.96% | -26.31M 11.86% | |
capital expenditure | -3.28M - | -3.51M 6.95% | -2.67M 23.95% | -3.15M 18.07% | -2.26M 28.29% | -1.74M 23.11% | -915K 47.32% | -665K 27.32% | |
free cash flow | -18.22M - | 64.22M 452.46% | -23.66M 136.84% | -29.24M 23.58% | -25.99M 11.12% | -22.33M 14.08% | -30.77M 37.78% | -26.97M 12.32% |
All numbers in (except ratios and percentages)